These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 5140093)

  • 61. Clinical and electromyographic examinations on the effect of hydrochloride (Viregyt-K) in the treatment of Parkinson's disease.
    Schubert U; Fischer GJ; Glass J
    Ther Hung; 1977; 25(2):55-63. PubMed ID: 898119
    [No Abstract]   [Full Text] [Related]  

  • 62. [Action of amantadine on parkinsonian tremor].
    Agnoli A; Casacchia M; Ruggieri S; Volante F; Accornero N
    Minerva Med; 1971 Oct; 62(82):3990-3. PubMed ID: 5125061
    [No Abstract]   [Full Text] [Related]  

  • 63. A double-blind evaluation of S.D. 25 in the treatment of Parkinson's disease.
    Strang RR
    Curr Med Drugs; 1966 Dec; 7(4):20-6. PubMed ID: 5976205
    [No Abstract]   [Full Text] [Related]  

  • 64. [The addition of amantadine to prolonged treatment with L-Dopa. Considerations on 20 cases].
    Giuffrè R; Gambacorta D
    Minerva Med; 1971 Oct; 62(82):4009-12. PubMed ID: 5125066
    [No Abstract]   [Full Text] [Related]  

  • 65. Recent advances in the treatment of Parkinsonism with drugs.
    Rinne UK
    Acta Neurol Scand Suppl; 1972; 51():59-103. PubMed ID: 4576076
    [No Abstract]   [Full Text] [Related]  

  • 66. The treatment of parkinsonism with L-Dopa and amantadine.
    Green J
    J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813
    [No Abstract]   [Full Text] [Related]  

  • 67. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 68. [On the action of amantadine in postencephalitic parkinsonism].
    Pennacchietti M; Aletto PM
    Minerva Med; 1971 Oct; 62(82):3960-2. PubMed ID: 5125052
    [No Abstract]   [Full Text] [Related]  

  • 69. Amantadine in the treatment of Parkinson's disease.
    Schwab RS; England AC; Poskanzer DC; Young RR
    JAMA; 1969 May; 208(7):1168-70. PubMed ID: 5818715
    [No Abstract]   [Full Text] [Related]  

  • 70. [Amantadine in the treatment of Parkinson's disease].
    Giombini S; Solero CL; Bazzan A; Ferrari P; Robotti E
    Fracastoro; 1970; 63(6):869-81. PubMed ID: 5519639
    [No Abstract]   [Full Text] [Related]  

  • 71. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
    Ambrosetto C; Martinelli P
    Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
    [No Abstract]   [Full Text] [Related]  

  • 72. Non-resting tremor in Parkinson's disease.
    Schwab RS; Young RR
    Trans Am Neurol Assoc; 1971; 96():305-7. PubMed ID: 5159117
    [No Abstract]   [Full Text] [Related]  

  • 73. [Our experience in the treatment of the parkinsonian syndrome with L-dopa. I. Evaluation of the clinical results].
    Bergamini L; Bonzanino O; Brignolio F; Fabiani A; Fariello R; Mombelli AM; Mutani R; Pisani W; Postir A; Riccio A; Sabbatini F; Sandigliano G; Schiffer D
    Riv Patol Nerv Ment; 1969 Oct; 90(5):329-49. PubMed ID: 5406104
    [No Abstract]   [Full Text] [Related]  

  • 74. Parkinson's disease: a clinical review.
    Lieberman AN
    Am J Med Sci; 1974 Feb; 267(2):66-80. PubMed ID: 4821328
    [No Abstract]   [Full Text] [Related]  

  • 75. [6 months of treatment with amantadine and L-Dopa. Comparison in 2 groups of patients with parkinsonism].
    Buscaino GA; Campanella G; Zallone E
    Minerva Med; 1971 Oct; 62(82):3974-8. PubMed ID: 5125057
    [No Abstract]   [Full Text] [Related]  

  • 76. [The treatment of Parkinson's syndrome with L-dopa].
    Völler GW; Kerstan J
    Nervenarzt; 1970 Mar; 41(3):138-44. PubMed ID: 5447886
    [No Abstract]   [Full Text] [Related]  

  • 77. Clinical evaluation of biperiden in Parkinson's disease.
    Strang RR
    Dis Nerv Syst; 1967 Mar; 28(3):191-3. PubMed ID: 5335879
    [No Abstract]   [Full Text] [Related]  

  • 78. Interactions of L-dopa and amantadine in patients with Parkinsonism.
    Cox B; Danta G; Schnieden H; Yuill GM
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):354-61. PubMed ID: 4714097
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
    Evtushenko SK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec; 76(12):1797-1802. PubMed ID: 1015115
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Amantadine and dexetimide in the treatment of parkinsonism].
    Hakkarainen H; Viukari M
    Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.